Original paper
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
Abstract
To present the pre-specified analyses of >5-years follow-up of the Phase III ALTTO trial.8381 patients with stage I-III HER2 positive breast cancer randomised to chemotherapy plus 1-year of trastuzumab (T), oral lapatinib (L; no longer evaluated), trastuzumab followed by lapatinib (T→L), and lapatinib + trastuzumab (L+T). The primary endpoint was disease-free survival (DFS). A secondary analysis examined DFS treatment effects by hormone receptor...
Paper Details
Title
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
Published Date
May 1, 2021
Journal
Volume
148
Pages
287 - 296
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History